Barclays Initiates Overweight Rating on Celestica Inc. (CLS), Citing Growth Potential in AI and Hyperscale Data Center Solutions

Full Article
Barclays Initiates Overweight Rating on Celestica Inc. (CLS), Citing Growth Potential in AI and Hyperscale Data Center Solutions

Barclays has initiated an overweight rating on Celestica Inc., highlighting the company's growth potential in AI and hyperscale data center solutions. The investment advisory firm Wedbush Securities anticipates a bullish market reaction for technology stocks, particularly in AI, if Donald Trump wins the upcoming election. Analysts predict that new AI initiatives from a Trump administration would significantly benefit major tech players.

Qualcomm is also in focus, with expectations of strong Q4 earnings driven by diversification into automotive and AI sectors. Despite challenges in the smartphone market, analysts foresee gains from Qualcomm's strategic shifts. The article emphasizes the importance of monitoring AI stocks, especially those favored by hedge funds, as they may outperform the market.

• Barclays sees growth potential in Celestica's AI and data center solutions.

• Qualcomm expected to report strong earnings amid AI sector diversification.

Key AI Terms Mentioned in this Article

AI Initiatives

New AI initiatives are expected to emerge under a Trump administration, benefiting tech firms.

Diversification

Qualcomm's diversification into automotive and AI sectors is anticipated to enhance its earnings.

Hyperscale Data Centers

Hyperscale data centers are crucial for supporting AI applications and large-scale data processing.

Companies Mentioned in this Article

Celestica

Celestica focuses on providing solutions for AI and hyperscale data centers, indicating strong growth potential.

Qualcomm

Qualcomm develops foundational technologies for wireless communication, with a growing focus on AI applications.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 6month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 6month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 6month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 6month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics